Real-life studies in allergen immunotherapy

Area of Science:

• Allergy and Immunology
• Real-World Evidence (RWE)
• Immunotherapy Research

Background:

• Randomized controlled trials (RCTs) have limitations in reflecting real-world treatment scenarios.
• Real-world studies are increasingly vital for evaluating treatment effectiveness and safety.
• The application of real-world methods to allergen immunotherapy is a growing area of research.

Purpose of the Study:

• To review the existing literature on real-world studies of allergen immunotherapy.
• To synthesize findings from real-world data that complement traditional RCTs.
• To highlight the value of real-world evidence in understanding allergen immunotherapy.

Main Methods:

• Systematic review of prospective and retrospective real-world studies on allergen immunotherapy.
• Analysis of literature published primarily within the last five years.
• Focus on studies examining adverse events, compliance, and long-term/preventive effects.

Main Results:

• Real-world studies provide novel information not obtainable from RCTs.
• Evidence suggests a generally favorable safety profile for allergen immunotherapy products.
• Studies indicate positive outcomes regarding compliance and long-term/preventive effects across different allergens.

Conclusions:

• Real-world studies offer valuable insights into allergen immunotherapy beyond controlled settings.
• These studies underscore the importance of a detailed approach to immunotherapy, acknowledging real-world complexities.
• The findings support the favorable profile of allergen immunotherapy in everyday clinical practice.